Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.

Moxidectin (MOX) is a milbemycin endectocide recently approved by the U.S. FDA for the treatment of onchocerciasis in persons at least 12 years of age. MOX has been shown to have a good safety profile in recent clinical trials. The efficacy of MOX for the treatment of lymphatic filariasis (LF) and i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yashpal S Chhonker, Catherine Bjerum, Veenu Bala, Allassane F Ouattara, Benjamin G Koudou, Toki P Gabo, Abdullah Alshehri, Abdoulaye Meïté, Peter U Fischer, Gary J Weil, Christopher L King, Philip J Budge, Daryl J Murry
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2023-08-01
coleção:	PLoS Neglected Tropical Diseases
Acesso em linha:	https://doi.org/10.1371/journal.pntd.0011567
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!